Delivery Order SPE2DR25D3017-SPE2DR26F3FE4
Award Date 1/5/26
Potential Completion Date 1/6/26
Potential Value $3.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for CellCept 500 mg tablets (500-count packages) valued at $12,029.30 under a firm fixed-price contract type. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical supply vehicle running through December 2026. CellCept (mycophenolate mofetil) is an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 250 mg capsules (100-count units) with a ceiling value of $1,382.42. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 250 mg capsules (100-count units) with a ceiling value of $1,261.78. The contract, issued on December 4, 2025, with an ultimate completion date of December 5, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement for pharmaceutical supply supporting federal medical needs, with performance occurring at...
- The Defense Logistics Agency awarded a delivery order valued at $9,024.78 to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.35 to AmerisourceBergen Drug Corp for 100 capsules of CellCept 250 mg, an immunosuppressant medication commonly used in transplant and autoimmune disease management. This firm fixed-price delivery order, awarded on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a competitively awarded contract with no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count packages) valued at $7,746.68 under a firm fixed-price contract. The award was made on December 16, 2025, with an ultimate completion date of December 17, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,014.65 to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count packages) on August 7, 2025, with a completion date of August 8, 2025. This non-competitive, firm fixed-price delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime contract vehicle (SPE2DX) that extends through December 2026. The product will be...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $34,182.88 for 100-count bottles of CellCept 500 mg tablets, with a completion date of December 3, 2025. This non-competitive delivery order was issued without a set-aside designation and represents a standard pharmaceutical procurement supporting military healthcare operations. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (500-count units) valued at $14,887.62 under a firm fixed-price contract. The award, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a non-competitive delivery order executed without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its Corporate Office location,...